What is the evidence allowing us to state that transcatheter aortic valve replacement via the femoral artery is a more attractive option compared to transapical valve replacement?

EuroIntervention

Volumn 7, Issue 8, 2011, Pages 903-904

  Kappetein, A Pieter ^a   Head, Stuart J ^a   Treede, Hendrik ^b   Reichenspurner, Hermann ^b   Mohr, Friedrich W ^c   Walther, Thomas ^d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d KERCKHOFF HEART CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE STENOSIS; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEVICES; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FEMORAL ARTERY; HEALTH CARE COST; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MEDICAL CARE; POSTOPERATIVE PAIN; QUALITY OF LIFE; SURGICAL APPROACH; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AORTIC VALVE; ENDOVASCULAR PROCEDURES; FEMORAL ARTERY; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84855410395     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I8A143     Document Type: Article

References (4)

1. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, ANderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-2198.
2. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-1607.
3. O'Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP, Society of Thoracic Surgeons Quality Measurement Task F. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2 - isolated valve surgery. Ann Thorac Surg. 2009;88:S23-42.
4. Schultz C, Moelker A, Tzikas A, Piazza N, de Feyter P, van Geuns RJ, Serruys PW, Krestin GP, de Jaegere P. The use of MSCT for the evaluation of the aortic root before transcutaneous aortic valve implantation: the Rotterdam approach. EuroIntervention 2010;6:505-511.